[Drug therapy of Parkinson's syndrome. Clinical long-term study using L-dopa and the drug conbination L-dopa-decarboxylase inhibitor].
D000596:Amino Acids; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000008:administration & dosage / Q000627:therapeutic use*; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*
D000596:Amino Acids; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D004338:Drug Combinations; D006834:Hydrazines; D004295:Dihydroxyphenylalanine
Die medikamentöse Therapie des Parkinson-Syndroms. Eine klinische Langzeitstudie mit L-Dopa und dem Kombinationspräparat L-Dopa-Decarboxylasehemmer.